Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Pediatrics Physician in Oakland, CA
NPI: 1083710891Primary Practice Location
UCSF BENIOFF CHILDREN'S HOSPITAL OAKLAND
747 52nd St, Oakland, CA
Primary Employer
UCSF Medical Center
ucsfhealth.org
HQ Phone
Get M.D. Robert's Phone Numberphone_androidMobile
Get M.D. Robert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2002 - 2025
UT State Medical License
1994 - 2004
American Board of Pediatrics
Pediatrics
American Board of Pediatrics
Pediatric Hematology-Oncology
University of Utah Health
Fellowship • Pediatric Hematology/Oncology
1994 - 1997
Children's Hospital-Oakland
Residency • Pediatrics
1991 - 1994
The Robert Larner, M.D. College of Medicine
uvm.edu
Medical School
Until 1991
Pulmonary coccidiomycosis masquerading as refractory metastatic Ewing sarcoma.
Authors: Michelle Hsiang, Elliot Stieglitz, Jeffry Simko
Journal: J Pediatr Hematol Oncol
CNS demyelination in fibrodysplasia ossificans progressiva
Authors: Kan, Lixin, Kitterman, Joseph A, Procissi, Daniele, Chakkalakal, Salin, Peng, Chian-Yu, McGuire, Tammy L, Goldsby, Robert E, Pignolo, Robert J, Shore, Eileen M, Kaplan, Frederick S, Kessler, John A
Journal: J Neurol
Publication Date: 2012-06-27
Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.
Authors: Louise Strong, Smita Bhatia, Gregory Armstrong
Publication Date: 2017-07-10
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Pharmacological Study, DRUG: Eribulin Mesylate
Lead Sponsor: Children's Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Cisplatin, PROCEDURE: Therapeutic Conventional Surgery, DRUG: Fluorouracil, DRUG: Vincristine Sulfate, PROCEDURE: Liver Transplantation, DRUG: Temsirolimus, DRUG: Irinotecan Hydrochloride, DRUG: Dexrazoxane, DRUG: Doxorubicin Hydrochloride
